About 5 results found for searched term "CP 55,940" (0.125 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M6626 | CP 55,940 | Others |
| CP 55,940 is a potent, non-selective cannabinoid receptor agonist. | ||
| M45339 | CP 55940 | Cannabinoid |
| CP-55,940 | ||
| CP 55940 is a variant full agonist of the CB1 receptor that exhibits high and approximately equal affinity for central and peripheral cannabinoid receptors, with Ki's of 0.6 - 5.0 and 0.7-2.6 nM for CB1 and CB2, respectively, and EC50 values of 0.2 and 0.3 nM for CB1 and CB2, respectively.In addition, when acting on GRP55, the EC50 value is 5 nM. | ||
| M5290 | (±)-SLV-319 | Cannabinoid |
| (±)-Ibipinibant; BMS-646256 | ||
| (±)-SLV319 (Ibipinabant) is a potent and selective CB1 receptor antagonist (Ki = 7.8 nM). Exhibits 1000-fold selectivity for CB1 over CB2 receptors. Inhibits CP 55,940-induced hypotension and WIN 55,212-2-induced hypothermia in vivo. | ||
| M29091 | ZCZ011 | Cannabinoid |
| ZCZ011 is a potent and brain penetrant cannabinoid 1 (CB1) receptor positive allosteric modulator. ZCZ011 potentiates binding of CP55,940 to the CB1 receptor, enhances anandamide (AEA)-stimulated GTPγS binding in mouse brain membranes. ZCZ011 increases β-arrestin recruitment and ERK phosphorylation in hCB1 cells. ZCZ011 can be used for researching neuropathic and inflammatory pain. | ||
| M30475 | Linoleoyl ethanolamide | Cannabinoid |
| Linoleic acid monoethanolamide | ||
| Linoleoyl ethanolamide (Linoleic acid monoethanolamide) is classified as a fatty acid ethanolamide. Linoleoyl ethanolamide only weakly binds G-protein-coupled cannabinoid receptors of type-1（CB1）and CB2 receptors, and inhibits the binding of [3H]CP-55,940 with Kis of 10 and 25 μM, respectively. Linoleoyl ethanolamide is 4-fold less potent than anandamide at causing catalepsy in mice and it does not prolong sleep time. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
